Literature DB >> 31997414

Changes in the relative prevalence of candidaemia due to non-albicans Candida species in adult in-patients: A systematic review, meta-analysis and meta-regression.

Daniele Roberto Giacobbe1,2, Alberto Enrico Maraolo3, Vittorio Simeon4, Federica Magnè1,2, Maria Caterina Pace5, Ivan Gentile3, Paolo Chiodini4, Claudio Viscoli1,2, Maurizio Sanguinetti6, Malgorzata Mikulska1,2, Marco Fiore5, Matteo Bassetti1,2.   

Abstract

BACKGROUND: Candidaemia remains associated with high mortality and increased costs worldwide.
OBJECTIVE: To assess the changes over time in the relative prevalence of non-albicans candidaemia (NAC).
METHODS: A systematic review, meta-analysis and meta-regression were performed. Observational studies investigating the epidemiology of consecutive, non-selected, candidaemia episodes were included. Two separated analyses were conducted: (a) whole hospital analysis and (b) intensive care unit (ICU) analysis.
RESULTS: Starting from an initial total of 7726 records, 220 studies fulfilled inclusion criteria. The pooled prevalence of NAC in whole hospital analysis was 49.5% (95% confidence intervals [CI] 48.0-51.1, I2 93.1%), while the pooled prevalence in ICU analysis was 50.6% (95% CI 46.6-54.6; I2 86.7%). In meta-regression, a progressive increase in NAC prevalence was observed in whole hospital analysis, although it explained only a small portion of between-study variance (estimated yearly prevalence change +0.3%, 95% CI from +0.1% to +0.5%, P = .003; adjusted R2 3.42%) and was observed only in some continents in subgroup analyses. No relevant changes over time were observed in NAC prevalence for ICU studies.
CONCLUSIONS: We registered an increasing trend in the relative prevalence of NAC, which, nonetheless, seems to be limited to some continents and to contribute only minimally to explain the observed differences in NAC prevalence across studies.
© 2020 Blackwell Verlag GmbH.

Entities:  

Keywords:  zzm321990Candidazzm321990; candidaemia; invasive candidiasis; meta-analysis; meta-regression; non-albicans; prevalence

Year:  2020        PMID: 31997414     DOI: 10.1111/myc.13054

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  9 in total

1.  Machine-learning based prediction and analysis of prognostic risk factors in patients with candidemia and bacteraemia: a 5-year analysis.

Authors:  Yali Gao; Mingsui Tang; Yaling Li; Xueli Niu; Jingyi Li; Chang Fu; Zihan Wang; Jiayi Liu; Bing Song; Hongduo Chen; Xinghua Gao; Xiuhao Guan
Journal:  PeerJ       Date:  2022-06-15       Impact factor: 3.061

2.  Current and promising pharmacotherapeutic options for candidiasis.

Authors:  Liliana Scorzoni; Beth Burgwyn Fuchs; Juliana Campos Junqueira; Eleftherios Mylonakis
Journal:  Expert Opin Pharmacother       Date:  2021-02-04       Impact factor: 3.889

3.  Characteristics of Extracellular Vesicles Released by the Pathogenic Yeast-Like Fungi Candida glabrata, Candida parapsilosis and Candida tropicalis.

Authors:  Justyna Karkowska-Kuleta; Kamila Kulig; Elzbieta Karnas; Ewa Zuba-Surma; Olga Woznicka; Elzbieta Pyza; Patryk Kuleta; Artur Osyczka; Maria Rapala-Kozik; Andrzej Kozik
Journal:  Cells       Date:  2020-07-18       Impact factor: 6.600

4.  Predominance of Candida Glabrata among Non-albicans Candida Species in a 16-Year Study of Candidemia at a Tertiary Care Center in Lebanon.

Authors:  Aline El Zakhem; Rachid Istambouli; Maria Alkozah; Amal Gharamti; Mohamad Ali Tfaily; Jean-Francois Jabbour; George F Araj; Hani Tamim; Souha S Kanj
Journal:  Pathogens       Date:  2021-01-19

5.  A new humanized antibody is effective against pathogenic fungi in vitro.

Authors:  Tomas Di Mambro; Tania Vanzolini; Pierpaolo Bruscolini; Sergio Perez-Gaviro; Emanuele Marra; Giuseppe Roscilli; Marzia Bianchi; Alessandra Fraternale; Giuditta Fiorella Schiavano; Barbara Canonico; Mauro Magnani
Journal:  Sci Rep       Date:  2021-09-30       Impact factor: 4.379

6.  The Catestatin-Derived Peptides Are New Actors to Fight the Development of Oral Candidosis.

Authors:  Davide Mancino; Naji Kharouf; Francesco Scavello; Sophie Hellé; Fouad Salloum-Yared; Angela Mutschler; Eric Mathieu; Philippe Lavalle; Marie-Hélène Metz-Boutigue; Youssef Haïkel
Journal:  Int J Mol Sci       Date:  2022-02-13       Impact factor: 5.923

7.  Insight Into the Properties and Immunoregulatory Effect of Extracellular Vesicles Produced by Candida glabrata, Candida parapsilosis, and Candida tropicalis Biofilms.

Authors:  Kamila Kulig; Elzbieta Karnas; Olga Woznicka; Patryk Kuleta; Ewa Zuba-Surma; Elzbieta Pyza; Artur Osyczka; Andrzej Kozik; Maria Rapala-Kozik; Justyna Karkowska-Kuleta
Journal:  Front Cell Infect Microbiol       Date:  2022-06-06       Impact factor: 6.073

8.  Epidemiology, Clinical Characteristics, Risk Factors, and Outcomes of Candidemia in a Large Tertiary Teaching Hospital in Western China: A Retrospective 5-Year Study from 2016 to 2020.

Authors:  Jie Hou; Jin Deng; Ya Liu; Weili Zhang; Siying Wu; Quanfeng Liao; Ying Ma; Mei Kang
Journal:  Antibiotics (Basel)       Date:  2022-06-09

9.  Combined Use of Presepsin and (1,3)-β-D-glucan as Biomarkers for Diagnosing Candida Sepsis and Monitoring the Effectiveness of Treatment in Critically Ill Patients.

Authors:  Radim Dobiáš; Marcela Káňová; Naděžda Petejová; Štefan Kis Pisti; Robert Bocek; Eva Krejčí; Helena Stružková; Michaela Cachová; Hana Tomášková; Petr Hamal; Vladimír Havlíček; Milan Raška
Journal:  J Fungi (Basel)       Date:  2022-03-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.